GoKawiilIngrid Zhang is taking the helm of the cancer therapy company, filling a post vacant since its previous CEO abruptly resigned in July.
Legend Names Novartis Executive as CEO
Why This Matters
Legend has ended a months-long leadership vacuum by hiring Novartis executive Ingrid Zhang as CEO, following its previous chief executive's abrupt July resignation. Stable leadership matters for a cancer therapy developer, where clinical and commercial execution depends on continuity and investor confidence.
Key Takeaways
- Ingrid Zhang, a Novartis executive, has been named CEO of cancer therapy company Legend.
- The role had been vacant since the prior CEO abruptly resigned in July.
- The hire brings big-pharma experience to a company needing leadership stability.
Get alerts for these topics